We are live on ! Find out more
BCM

BlueCrest Capital Management Portfolio holdings

AUM $1.69B
1-Year Est. Return 20.01%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+20.01%
3 Year Est. Return
+41.66%
5 Year Est. Return
+41.11%
10 Year Est. Return
+377.48%
AUM
$3.86B
AUM Growth
+$648M
Cap. Flow
+$522M
Cap. Flow %
13.54%
Top 10 Hldgs %
27.7%
Holding
2,121
New
678
Increased
371
Reduced
368
Closed
674

Sector Composition

Rank Sector Weight
1 Technology 10.14%
2 Industrials 8%
3 Healthcare 7.93%
4 Financials 7.7%
5 Energy 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWOU
76
DELISTED
2U Inc
TWOU
$9.7M 0.25%
3,869
+3,386
+701% +$8.99M
NXPI icon
77
NXP Semiconductors
NXPI
$60.8B
$9.56M 0.25%
87,475
+7,281
+9% +$803K
RNG icon
78
RingCentral
RNG
$4.83B
$9.47M 0.25%
134,569
+126,862
+1,646% +$9.08M
NTNX icon
79
Nutanix
NTNX
$16.1B
$9.34M 0.24%
181,035
+160,419
+778% +$8.82M
GRUB
80
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$9.27M 0.24%
44,179
+36,512
+476% +$7.56M
RRC icon
81
Range Resources
RRC
$9.33B
$9.23M 0.24%
+551,632
New +$8.35M
B
82
CALL
Barrick Mining
B
$60.9B
$9.19M 0.24%
700,000
+390,900
+126% +$5.13M
XLK icon
83
State Street Technology Select Sector SPDR ETF
XLK
$109B
$9.15M 0.24%
263,460
-543,636
-67% -$18.7M
FCNCA icon
84
First Citizens BancShares
FCNCA
$24.7B
$8.83M 0.23%
21,887
+20,861
+2,033% +$8.99M
VR
85
DELISTED
Validus Hold Ltd
VR
$8.78M 0.23%
129,801
+104,801
+419% +$7.09M
YUM icon
86
Yum! Brands
YUM
$41.9B
$8.65M 0.22%
110,589
+100,971
+1,050% +$8.42M
GSK icon
87
GSK
GSK
$107B
$8.52M 0.22%
+169,170
New +$8.52M
XLU icon
88
State Street Utilities Select Sector SPDR ETF
XLU
$23.1B
$8.39M 0.22%
322,856
-859,038
-73% -$21.6M
IBB icon
89
iShares Biotechnology ETF
IBB
$9.45B
$8.37M 0.22%
76,212
+64,237
+536% +$6.87M
MTB icon
90
M&T Bank
MTB
$36.3B
$8.33M 0.22%
48,949
+43,183
+749% +$7.74M
GLD icon
91
CALL
SPDR Gold Trust
GLD
$131B
$8.31M 0.22%
70,000
-10,000
-13% -$1.24M
CTAS icon
92
Cintas
CTAS
$86.6B
$8.25M 0.21%
178,300
+163,424
+1,099% +$7.35M
CTLT
93
DELISTED
CATALENT, INC.
CTLT
$8.03M 0.21%
191,686
+178,615
+1,366% +$7.22M
ESV
94
DELISTED
Ensco Rowan plc
ESV
$7.83M 0.2%
269,452
+174,736
+184% +$4.28M
HD icon
95
Home Depot
HD
$337B
$7.76M 0.2%
+39,784
New +$7.43M
SRPT icon
96
Sarepta Therapeutics
SRPT
$1.64B
$7.75M 0.2%
58,629
+54,220
+1,230% +$5.11M
UI icon
97
Ubiquiti
UI
$31.6B
$7.71M 0.2%
91,050
+87,111
+2,212% +$6.83M
NKTR icon
98
Nektar Therapeutics
NKTR
$2.39B
$7.71M 0.2%
10,529
+10,049
+2,094% +$11.6M
Y
99
DELISTED
Alleghany Corp
Y
$7.61M 0.2%
+13,237
New +$7.73M
EHC icon
100
Encompass Health
EHC
$11.3B
$7.41M 0.19%
137,621
+116,130
+540% +$5.8M

Similar funds

BlueCrest Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, BlueCrest Capital Management held 2,121 positions worth $3.86B, up 20% from $3.21B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

BlueCrest Capital Management deployed $522M of net new capital in Q2 2018, opening 678 new positions and adding to 371 existing holdings. Its largest new stake was PepsiCo: 255,960 shares worth $27.9M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 6.3% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Nutrien, an estimated $42.4M trimmed.

  • BlueCrest Capital Management's largest Q2 2018 buy was PepsiCo: 255,960 shares worth $27.9M.
  • BlueCrest Capital Management added most to State Street Financial Select Sector SPDR ETF in Q2 2018, an estimated $91.2M increase.
  • BlueCrest Capital Management's biggest Q2 2018 reduction was Nutrien, cutting an estimated $42.4M.
  • BlueCrest Capital Management fully exited iShares MSCI Emerging Markets ETF in Q2 2018, selling an estimated $19.8M.
  • BlueCrest Capital Management's ten largest holdings make up 28% of its $3.86B portfolio in Q2 2018.
  • BlueCrest Capital Management opened 678 new positions and closed 674 in Q2 2018.
  • BlueCrest Capital Management's portfolio value rose 20% quarter-over-quarter to $3.86B.

Based on BlueCrest Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.